Keyword search

View results

Filter results by

Search Help
Currently selected filters that can be removed
Remove Remove "Health" filterRemove Remove "Diseases and physical health conditions" filter
Clear all

Keyword(s)

Subject

Type

7 facets displayed. 0 facets selected.

Year of publication

33 facets displayed. 0 facets selected.

Geography

8 facets displayed. 0 facets selected.

Survey or statistical program

40 facets displayed. 0 facets selected.

Portal

Content

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (661)

All (661) (0 to 10 of 661 results)

  • 1. Geographic variation in female breast cancer incidence and mortality in Canada
    Articles and reports: 82-003-X202600500001
    Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).
    Release date: 2026-05-20
  • 2. Enhancing the OncoSim-Breast model using Canadian breast density information
    Articles and reports: 82-003-X202600500002
    Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.
    Release date: 2026-05-20
  • 3. Weight change over time and obesity in Canada
    Stats in brief: 11-627-M2026019
    Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.
    Release date: 2026-04-09
  • 4. Assessing obesity beyond body mass index: Integrating physiological and functional indicators of impairment in national health surveillance
    Articles and reports: 82-003-X202600300001
    Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.
    Release date: 2026-03-18
  • 5. Cardiovascular health measures of the household population
    Table: 13-10-0326-01
    Geography: Canada
    Frequency: Occasional
    Description: Cardiovascular health measures of the household population, by sex and age group.
    Release date: 2026-03-10
  • 6. Number and rates of new cases of primary cancer, by cancer type, age group and sex
    Table: 13-10-0111-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description:

    Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

    Release date: 2026-02-27
  • 7. Number of new cases and age-standardized rates of primary cancer, by cancer type and sex
    Table: 13-10-0747-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description:

    The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

    Release date: 2026-02-27
  • 8. Deaths, by cause, Chapter I: Certain infectious and parasitic diseases (A00 to B99)
    Table: 13-10-0141-01
    Geography: Canada
    Frequency: Annual
    Description: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.
    Release date: 2026-01-13
  • 9. Deaths, by cause, Chapter II: Neoplasms (C00 to D48)
    Table: 13-10-0142-01
    Geography: Canada
    Frequency: Annual
    Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.
    Release date: 2026-01-13
  • 10. Deaths, by cause, Chapter IV: Endocrine, nutritional and metabolic diseases (E00 to E90)
    Table: 13-10-0144-01
    Geography: Canada
    Frequency: Annual
    Description: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.
    Release date: 2026-01-13
Data (226)

Data (226) (40 to 50 of 226 results)

  • 41. Long term COVID-19 symptoms among Canadian adults who self-reported a prior positive test or suspected SARS-CoV-2 infection, by sex and age group
    Table: 13-10-0867-01
    Geography: Canada
    Frequency: Occasional
    Description: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.
    Release date: 2023-08-03
  • 42. Self-reported positive COVID-19 tests and suspected infections in the adult Canadian population by region, sex and age group
    Table: 13-10-0868-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.
    Release date: 2023-08-03
  • 43. Fire-related deaths and persons injured, by cause of death or injury and reason for non-evacuation
    Table: 35-10-0194-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by type of casualty, age group of casualty, status of casualty, cause of death or injury and reason for non-evacuation, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08
  • 44. Fire-related deaths and persons injured, by type of structure
    Table: 35-10-0195-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by type of casualty, age group of casualty, status of casualty and type of structure, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08
  • 45. Incident-based fire statistics, by performance of smoke alarm device, residential fires
    Table: 35-10-0196-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by performance of smoke alarm device, residential fires and type of incident and casualty, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08
  • 46. Incident-based fire statistics, by performance of sprinkler system, structural fires
    Table: 35-10-0197-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by performance of sprinkler system, structural fires and type of incident and casualty, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08
  • 47. Canadian COVID-19 Antibody and Health Survey Cycle 2: Public Use Microdata File of SARS-CoV-2 Genetic Sequences
    Public use microdata: 13-25-0009
    Description: This public use microdata file (PUMF) provides researchers access to data on the distribution of SARS-CoV-2 lineages detected in the Canadian provinces between May and September 2022. Samples were collected as part of the Canadian COVID-19 Antibody and Health Survey (CCAHS), Cycle 2. The PUMF file consists of a subset of participants of the CCAHS who submitted a positive PCR saliva sample over the course of the collection of the survey. The PUMF contains select demographic information including sex at birth, age group, province and the week of collection. The file also contains SARS-CoV-2 whole genome sequences and its associated data.
    Release date: 2023-05-25
  • 48. Cancer incidence trends, by sex and cancer type
    Table: 13-10-0840-01
    Frequency: Occasional
    Description:

    Annual percent change and average annual percent change in age-standardized cancer incidence rates since 1984 to the most recent diagnosis year. The table includes a selection of commonly diagnosed invasive cancers, as well as in situ bladder cancer. Cases are defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3) from 1992 to the most recent data year and on the International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1991.

    Release date: 2023-05-16
  • 49. Canadians' health and COVID-19, by region and select sociodemographic characteristics
    Table: 13-10-0865-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Semi-annual
    Description: This table presents a series of indicators relating to the COVID-19 pandemic, including relating to perceptions of Canadians' mental health, precautions they've taken, willingness to receive vaccine and the number of vaccinated and unvaccinated persons. Estimates are based on preliminary bi-annual data from the Canadian Community Health Survey, and are provided for the Canadian population aged 18 and older excluding the territories, by region of residence and other demographic characteristics.
    Release date: 2023-04-25
  • 50. SARS-CoV-2 antibody seroprevalence from past infection, by region, sex and age group
    Table: 13-10-0866-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
    Release date: 2023-03-27
Analysis (414)

Analysis (414) (0 to 10 of 414 results)

  • 1. Geographic variation in female breast cancer incidence and mortality in Canada
    Articles and reports: 82-003-X202600500001
    Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).
    Release date: 2026-05-20
  • 2. Enhancing the OncoSim-Breast model using Canadian breast density information
    Articles and reports: 82-003-X202600500002
    Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.
    Release date: 2026-05-20
  • 3. Weight change over time and obesity in Canada
    Stats in brief: 11-627-M2026019
    Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.
    Release date: 2026-04-09
  • 4. Assessing obesity beyond body mass index: Integrating physiological and functional indicators of impairment in national health surveillance
    Articles and reports: 82-003-X202600300001
    Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.
    Release date: 2026-03-18
  • 5. Screens Replaced Play, and Our Bodies Noticed
    Stats in brief: 45-20-00032025008
    Description: Has Canada become a sedentary nation? Health data have never been more accessible. We have smart watches to count our steps, notifications about our screen times and apps to track our daily diets. Despite the futuristic tech, researchers are growing concerned. And they’re especially concerned about young Canadians. Today we sat down with Rachel Colley, a senior health researcher at StatCan for a deep dive into Canada’s obesity, physical activity and screen time trends. And the new data from the Canadian Health Measures survey may surprise you.
    Release date: 2025-11-21
  • 6. Breast cancer incidence in Canada
    Stats in brief: 11-627-M2025054
    Description: This infographic highlights breast cancer statistics from the Canadian Cancer Registry (CCR). Breast cancer incidence is presented, as well as survival rates for women in Canada.
    Release date: 2025-10-29
  • 7. The OncoSim-Cervix cancer microsimulation model: Unveiling roll-out strategies for human papillomavirus primary testing
    Articles and reports: 82-003-X202501000002
    Description: Globally, cervical cancer is one of the most common cancers, yet it is largely preventable. Switching methods for primary screening from cytology testing, via Pap test, to human papillomavirus (HPV) testing is a component of that prevention. OncoSim-Cervix, a Canadian cervical cancer microsimulation model, assesses the long-term effects of HPV vaccination and screening interventions. This study projects the impact of differing roll-out strategies for HPV primary testing for cervical cancer screening in Canada.
    Release date: 2025-10-15
  • 8. The prevalence of overweight and obesity is on the rise in Canada: New results from the Canadian Health Measures Survey 2022 to 2024
    Stats in brief: 11-001-X202527540810
    Description: Release published in The Daily – Statistics Canada’s official release bulletin
    Release date: 2025-10-02
  • 9. Living with a life-limiting illness: A 2024 national crowdsourced study of experiences and access to care
    Stats in brief: 11-001-X202527439866
    Description: Release published in The Daily – Statistics Canada’s official release bulletin
    Release date: 2025-10-01
  • 10. Metabolic syndrome in Canadian adults, 2007 to 2019
    Articles and reports: 82-003-X202500900001
    Description: Metabolic syndrome (MetS) is a clustering of multiple risk factors, including abdominal obesity (or high waist circumference), elevated triglycerides, low high-density lipoprotein cholesterol, high fasting blood glucose, and high blood pressure. MetS is an important contributor to cardiovascular disease and type 2 diabetes. Research indicates that MetS doubles the risk of cardiovascular disease and increases the risk of diabetes fivefold. Using the most recent nationally representative data from the Canadian Health Measures Survey, this study provides an updated prevalence of MetS and its components among Canadian adults aged 18 to 79 years by age group and sex.
    Release date: 2025-09-17
Reference (21)

Reference (21) (20 to 30 of 21 results)

  • 21. COVID-19 epidemiological reports
    Surveys and statistical programs – Documentation: 5319
    Description: The data contain detailed confirmed cases of coronavirus disease (COVID-19) in Canada, which is compiled by the Public Health Agency of Canada, with the contribution from provincial and territorial Health ministries.

Sort Help

How are the results ordered?

The Sort by feature provides four options:

  • By date – sorts results by product release date starting with the most recent.
  • By most popular – gives priority to results that are most frequently selected by users, followed by the most recent.
  • By relevance is only needed or beneficial when you use the search box and submit a search query. Results are ordered by a combination of where the search term appears in the content, e.g., if it appears in the title, it likely means the product is more relevant to your search; how up to date or new the content in the product is; how popular the product is; and other factors.
  • By title – sorts results alphabetically.

Sort Help

How are the results ordered?

The Sort by feature provides three options:

  • By date – sorts results by product release date starting with the most recent.
  • By relevance is only needed or beneficial when you use the search box and submit a search query. Results are ordered by a combination of where the search term appears in the content, e.g., if it appears in the title, it likely means the product is more relevant to your search; how up to date or new the content in the product is; how popular the product is; and other factors.
  • By title – sorts results alphabetically.

Search Help

How do I use the filters and the search box?

  • You can initiate a search by entering keywords or selecting filters (e.g., under Subject, Geography, etc.) on the left side of the page.

  • Filters can be used together or in any combination. Each time you select a filter, the results on the page are updated.

  • To start a new search, click on the Clear all button above the search box or deselect each filter.

  • Specified keywords and filters appear above the search box. You can deselect any or all the tags to refine or clear your search.

How do I refine my search?

  • You can enter keywords in the search box. It is not necessary to use “+” or “, “ or “AND”.

  • You can delete some or all of the keywords from your search string.

  • Quotes around keywords limit the search to a specific phrase.

    • For example, “labour force survey” will limit results to products containing this phrase.

  • Use “or” between keywords to obtain results that contain one or more search terms.

    • For example, labour or­ force or survey will limit results to products containing any or all of these words.

How does the search work?

  • This search looks for results that have your query term in the title, description, subject, geography, product number or other information about the product.

    • For example, when searching the term ‘Diseases’, all results with the word ‘Diseases’ in the title, description or tagged the subject appear.

  • The text within an article or publication are not searched. For full text searching of articles, use the site search.

Date modified: